Jeffery Alvarez Presents Moon Surgical at LSI Europe '23

Transcription

Jeffery Alvarez  0:05  
Jeff Alvarez, the Chief Strategy Officer in Moon Surgical, we're focused on increasing the efficiency of healthcare delivery for every patient in every operating room. Now, I think we can all agree that the US healthcare system is in trouble. Over the last 10 years, we've seen 136 different hospitals go out of business. And this has left entire communities without access to care. Places like Sonora, California, and Clinton, Pennsylvania. It's just going to continue because what we're seeing today is that 49% of hospitals are operating at a deficit. And a large part of that has to do with staffing costs. There's significant turnover, there's significant staffing shortages, and the gap is getting closed with temporary staff, which costs almost twice as much. We're going to see in the future that this trend is going to continue. And it's also going to move into a deficit of surgeons. Access to care is definitely in jeopardy. At Moon Surgical, we're focused on changing the trajectory of this problem. It's in one of the largest surgical categories in hospitals today, which is laparoscopy, it makes up 13 million procedures annually. And it's a very manual tedious and highly variable, procedure. At Moon, we're enabling the operating room of tomorrow. That's powered by the Maestro ecosystem. It is solving systematic issues across laparoscopy operating rooms, and delivering benefits to doctors, nurses, patients, and hospitals. We improve confidence of the surgeon usability, increased access and ultimately help improve the bottom line. Less staff in the operating room overall, with fewer complications, less pain, less fatigue for the surgeon, and less staff turnover. The system, which you see on the right can actually set itself up based on the surgeons preferences. It adapts off the shelf instruments to it that can be then roboticized and allows the surgeon to actually operate with much less staff in the room. It has autonomous scope capabilities and can be quickly re adjusted for port hopping or multi quadrant surgery. The system is also very easy to use very fluid, and is at the center of the operating room, where we can understand the position of the table how things are changing, and guide the system in its placement intraoperatively we can actually see the different stages and interpret the different stages of a procedure so that we know where we're at in the procedure, as well as start to identify critical tissues and anatomies. The system has a lot of unique capabilities, it's a very small footprint, and so it can fit into a lot of different operating rooms. It's has two very resistant free arms that are easy to move around and allow the fluidness of laparoscopy to be maintained. Again, it gauges off the shelf instruments. So preferred instruments that that a surgeon has can be attached to the system and they can use it in any procedure that they would like. The system has a lot of unique sensing as well. It's instrumented with three dimensional cameras so that we can observe where the surgeon is where their staff is the bed and make lots of interpretations from it. The arms themselves are high force sensors so that we understand surgical technique and the intent that the surgeon has on interacting with the tissue. And lastly, we have a variety of proximity sensors that understand how things are moving around the system, just like we have in today's cars. The overall ecosystem is comprised of four parts. It has the makeup Maestro system at its core, the Access Program, which is focused on enabling systems to be placed in every operating room in any facility and ensuring that all patients have access to the latest technology. The O R intelligence program brings in a lot of the data that our system collects and really starts to close the loop for the first time In the operating room and become the operating system of the O R, driving continuous improvement, and then customer success, ensuring that every touchpoint with our customer is a well curated experience using modern tools, simplified billing, and, you know, data driven customer service. So how does it all work, the operating room has Maestro in the center. And this Maestro can actually bring in information like the staff configuration, equipment, locations, instrument types, the surgical approach being used and the timing of the procedure, all of that data is brought in and can be sent up to our cloud where it is then analyzed and interpreted. And then fed into our Customer Success Program, where we'd run system diagnostics, we use it to drive our service and repair activities. We offload and manage inventory of all of our consumables, and then improve our training as new people are coming in and out of that hospital as well. The last thing is we generate insights from all of these analytics, and are able to provide that back to the hospital, the staff and the surgeon in insights where they can then translate it into action and improve the experience in the operating room. Now, one of the things that's really important is the market that we're going after, and this is why I can have such a big impact in hospitals today. Today, there's over 30,000 laparoscopy rooms in the United States. And after 20 years of robotic commercialization, there's only a little over 4800 robotic systems in use in these operating rooms. The amount of real estate out there is significant. These operating rooms perform over 13 million laparoscopy fees every year. And compared to the robotic approach that's only 780,000. Were clinical stage company. We did a lot of development in engaging surgeons. In cadaver labs. We've done 55 procedures in humans across seven indications highlighting the flexibility and adaptability of our system. Administrators love it. We did a lot of interviews in the development and as well, here's a CFO talking about how fantastic the system is and how excited he is. Surgeons love it. They say it's an absolute joy to use and they would use it every day as well. We have a great team of leaders that have lots of experience in surgical robotics as well as a board that is well recognized in the industry, including our chairman, Dr. Fred Moll. In terms of our timeline, we really got started at the beginning of 2021 with a 5 million seed and we were able to assemble our team of eight people design a robot and get it into a first human clinical. By mid 2022. We raised this 31 million series A led by GE Healthcare and participation by J&J. We use that to design our commercial system, which I'm happy to report has just received CE mark yesterday. We've just recently closed a 55 million series be led by Sofinnova Partners and NVIDIA ventures as well. We'll be doing an EU pilot at the end of this month and starting a limited market release in the United States and in January of 2024. And Moon Surgical we're always interested in connecting with bankers and investors and like minded entrepreneurs that love this space and we're happy to talk with you. Thank you